NCT06575712 Coping Skills Training for Symptom Management and Daily Steps (Step Up)
| NCT ID | NCT06575712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Hematopoietic Stem Cell Transplant |
| Study Type | INTERVENTIONAL |
| Enrollment | 177 participants |
| Start Date | 2025-04-21 |
| Primary Completion | 2028-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 177 participants in total. It began in 2025-04-21 with a primary completion date of 2028-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to test the efficacy of a hybrid in-person and mHealth coping skills training and activity coaching intervention (Step Up), to enable HCT patients to effectively cope with symptoms (pain, fatigue, and stress) to improve their ability to engage in physical activity that can improve physical disability.
Eligibility Criteria
Inclusion Criteria: * receipt of an autologous (auto) HCT or CAR-T cell therapy due to a hematologic malignancy, such as a diagnosis of leukemia, lymphoma, multiple myeloma * age \>18 * self-reported fatigue, pain, and psychological distress (confirmed at recruitment) - minimum two of three symptoms reported at \>3 on 0-10 scale * life expectancy \> 12 months Exclusion Criteria: * cognitive impairment (e.g., dementia) recorded in the chart or suspected by provider * metastases to the brain * presence of a severe psychiatric condition (e.g., psychotic disorder) that would contraindicate safe participation as indicated by the medical chart, treating oncologist, or interactions with the medical/study staff * inability to converse in English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06575712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Hematopoietic Stem Cell Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06575712 currently recruiting?
Yes, NCT06575712 is actively recruiting participants. Contact the research team at allison.diachina@duke.edu for enrollment information.
Where is the NCT06575712 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT06575712 clinical trial?
NCT06575712 is sponsored by Duke University. The trial plans to enroll 177 participants.